diquafosol has been researched along with uridine in 5 studies
| Studies (diquafosol) | Trials (diquafosol) | Recent Studies (post-2010) (diquafosol) | Studies (uridine) | Trials (uridine) | Recent Studies (post-2010) (uridine) |
|---|---|---|---|---|---|
| 126 | 38 | 92 | 12,749 | 69 | 1,083 |
| Protein | Taxonomy | diquafosol (IC50) | uridine (IC50) |
|---|---|---|---|
| Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.8 | |
| Solute carrier family 28 member 3 | Homo sapiens (human) | 5.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, WM; Boucher, RC; Boyer, J; Cowlen, M; Davis, CW; Dougherty, R; Jones, AC; Lang-Furr, M; Picher, M; Sabater, JR; Stutts, MJ; Yerxa, BR | 1 |
| Evans, R; Kellerman, D; Mathews, D; Shaffer, C | 1 |
| Amar, T; Caillaud, T; Douglass, JG; Edick, C; Elena, PP; Peterson, WM; Yerxa, BR | 1 |
| Engels, J; Gorden, J; Kellerman, D; Rossi Mospan, A; Schaberg, A; Smiley, L | 1 |
| Appy, L; Chardet, C; Peyrottes, S; Roy, B | 1 |
3 review(s) available for diquafosol and uridine
| Article | Year |
|---|---|
Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease.
Topics: Administration, Inhalation; Animals; Clinical Trials as Topic; Cystic Fibrosis; Deoxycytosine Nucleotides; Epithelium; Humans; Mucociliary Clearance; Ophthalmic Solutions; Polyphosphates; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2Y2; Uracil Nucleotides; Uridine | 2002 |
Denufosol: a review of studies with inhaled P2Y(2) agonists that led to Phase 3.
Topics: Administration, Inhalation; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cystic Fibrosis; Deoxycytosine Nucleotides; Female; Forced Expiratory Volume; Humans; Male; Polyphosphates; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2Y2; Uracil Nucleotides; Uridine | 2008 |
Synthetic Strategies for Dinucleotides Synthesis.
Topics: Deoxycytosine Nucleotides; Dinucleoside Phosphates; Dry Eye Syndromes; Green Chemistry Technology; Humans; Ophthalmic Solutions; Phosphorylation; Polyphosphates; Purinergic P2Y Receptor Agonists; Receptors, Purinergic; Uracil Nucleotides; Uridine | 2019 |
2 other study(ies) available for diquafosol and uridine
| Article | Year |
|---|---|
Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis.
Topics: Animals; Astrocytoma; Brain Neoplasms; Calcium; Chlorides; Cilia; Cystic Fibrosis; Deoxycytosine Nucleotides; Epithelial Cells; Humans; In Situ Hybridization; In Vitro Techniques; Indicators and Reagents; Macaca mulatta; Mucins; Mucociliary Clearance; Ophthalmic Solutions; Polyphosphates; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Reverse Transcriptase Polymerase Chain Reaction; Sheep; Tumor Cells, Cultured; Uracil Nucleotides; Uridine | 2002 |
Potency and duration of action of synthetic P2Y2 receptor agonists on Schirmer scores in rabbits.
Topics: Animals; Deoxycytosine Nucleotides; Eye; Male; Ophthalmic Solutions; Polyphosphates; Purinergic P2 Receptor Agonists; Rabbits; Tears; Uracil Nucleotides; Uridine | 2002 |